The latest closing stock price for Monte Rosa Therapeutics as of November 22, 2024 is 8.49.
An investor who bought $1,000 worth of Monte Rosa Therapeutics stock at the IPO in 2021 would have $-599 today, roughly -1 times their original investment - a -26.27% compound annual growth rate over 3 years.
The all-time high Monte Rosa Therapeutics stock closing price was 42.21 on September 03, 2021.
The Monte Rosa Therapeutics 52-week high stock price is 12.40, which is 46.1% above the current share price.
The Monte Rosa Therapeutics 52-week low stock price is 2.91, which is 65.7% below the current share price.
The average Monte Rosa Therapeutics stock price for the last 52 weeks is 5.52.
An investor who bought $1,000 worth of Monte Rosa Therapeutics stock at the IPO in 2021 would have $-599 today, roughly -1 times their original investment - a -26.27% compound annual growth rate over 3 years.
The all-time high Monte Rosa Therapeutics stock closing price was 42.21 on September 03, 2021.
The Monte Rosa Therapeutics 52-week high stock price is 12.40, which is 46.1% above the current share price.
The Monte Rosa Therapeutics 52-week low stock price is 2.91, which is 65.7% below the current share price.
The average Monte Rosa Therapeutics stock price for the last 52 weeks is 5.52.